China A-share CRO sector strengthened, with Aopumai up more than 6% and Wanbang Pharmaceutical rising over 4%; Heyuan Bio, Xinghao Pharmaceutical and Baihua Pharmaceutical also advanced.

2026-10-29

China A-share CRO sector strengthened, with Aopumai up more than 6% and Wanbang Pharmaceutical rising over 4%; Heyuan Bio, Xinghao Pharmaceutical and Baihua Pharmaceutical also advanced.